DABABNEH, HUSSAM MUSA SALEM
 Distribuzione geografica
Continente #
NA - Nord America 4.434
AS - Asia 3.756
EU - Europa 3.059
AF - Africa 346
SA - Sud America 187
OC - Oceania 11
AN - Antartide 1
Totale 11.794
Nazione #
US - Stati Uniti d'America 4.343
VN - Vietnam 1.190
SG - Singapore 1.024
CN - Cina 845
GB - Regno Unito 825
IT - Italia 494
DE - Germania 415
SE - Svezia 326
FR - Francia 224
HK - Hong Kong 217
RU - Federazione Russa 172
IN - India 170
TG - Togo 136
BR - Brasile 134
IE - Irlanda 133
NL - Olanda 107
ZA - Sudafrica 76
FI - Finlandia 66
CA - Canada 64
UA - Ucraina 61
EE - Estonia 58
CI - Costa d'Avorio 53
JO - Giordania 52
NG - Nigeria 45
BE - Belgio 39
JP - Giappone 38
BD - Bangladesh 34
BG - Bulgaria 28
TH - Thailandia 27
IR - Iran 23
AR - Argentina 22
PH - Filippine 19
CH - Svizzera 18
LT - Lituania 18
PL - Polonia 18
TR - Turchia 18
IQ - Iraq 17
MX - Messico 15
TW - Taiwan 15
EC - Ecuador 12
ES - Italia 12
ID - Indonesia 12
PK - Pakistan 12
AT - Austria 11
AU - Australia 10
RO - Romania 8
CZ - Repubblica Ceca 7
ET - Etiopia 7
GR - Grecia 7
SC - Seychelles 7
UZ - Uzbekistan 7
KR - Corea 6
AE - Emirati Arabi Uniti 5
CL - Cile 5
EG - Egitto 5
LB - Libano 5
JM - Giamaica 4
MY - Malesia 4
UY - Uruguay 4
VE - Venezuela 4
AZ - Azerbaigian 3
GH - Ghana 3
KE - Kenya 3
SN - Senegal 3
AL - Albania 2
BF - Burkina Faso 2
CO - Colombia 2
DK - Danimarca 2
DO - Repubblica Dominicana 2
KG - Kirghizistan 2
OM - Oman 2
PS - Palestinian Territory 2
PY - Paraguay 2
RS - Serbia 2
SY - Repubblica araba siriana 2
AO - Angola 1
AQ - Antartide 1
BB - Barbados 1
BH - Bahrain 1
BO - Bolivia 1
BZ - Belize 1
GD - Grenada 1
HR - Croazia 1
HU - Ungheria 1
KH - Cambogia 1
LC - Santa Lucia 1
LY - Libia 1
MA - Marocco 1
MN - Mongolia 1
MZ - Mozambico 1
NO - Norvegia 1
NP - Nepal 1
NZ - Nuova Zelanda 1
PA - Panama 1
PE - Perù 1
PT - Portogallo 1
RW - Ruanda 1
SA - Arabia Saudita 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 11.792
Città #
Southend 705
Singapore 704
Ashburn 591
Chandler 486
Fairfield 284
San Jose 246
Hong Kong 201
Santa Clara 194
Dong Ket 180
Ho Chi Minh City 180
Hanoi 179
Wilmington 171
Houston 169
Seattle 162
Princeton 153
Lomé 136
Dublin 132
Ann Arbor 127
Beijing 122
Woodbridge 113
Cambridge 93
Nanjing 85
Boardman 79
Lauterbourg 72
Westminster 70
Padova 68
New York 67
Los Angeles 58
Abidjan 53
Amman 52
Berlin 52
Medford 51
Jinan 50
Helsinki 49
Shenyang 47
Bremen 46
Bologna 44
Milan 42
Abeokuta 41
London 40
Saint Petersburg 39
Turin 39
Brussels 38
Frankfurt am Main 37
Dearborn 35
Haiphong 34
Munich 33
São Paulo 33
Hebei 32
Tokyo 31
Dallas 30
Buffalo 29
Tianjin 28
Da Nang 27
Redondo Beach 27
Sofia 26
Nanchang 25
Guangzhou 23
Jacksonville 22
Florence 21
Mountain View 20
Toronto 20
Changsha 19
Basingstoke 18
Hangzhou 18
Montreal 18
Falkenstein 17
Phoenix 17
Redwood City 17
San Diego 16
Turku 16
Haikou 15
Pune 14
Düsseldorf 13
Rome 13
Fuzhou 12
Biên Hòa 11
Falls Church 11
Ningbo 11
Ottawa 11
Taiyuan 11
Warsaw 11
Yubileyny 11
Bexley 10
Chicago 10
Hải Dương 10
Jiaxing 10
Mülheim 10
Olalla 10
San Francisco 10
Nuremberg 9
Shanghai 9
Stockholm 9
Taizhou 9
Torino 9
Atlanta 8
Kunming 8
Norwalk 8
Shenzhen 8
Zanjan 8
Totale 7.498
Nome #
Adverse Features and Competing Risk Mortality in Patients With High-Risk Prostate Cancer 284
Sex-related penile fracture with complete urethral rupture: A case report and review of the literature 255
ACCURACY OF PET/CT WITH 11-C-CHOLINE IN THE RESTAGING OF RECURRENT PROSTATE CANCER PATIENTS WITH A SINGLE LESION AT BONE SCINTIGRAPHY 244
Can we consider eligible for active surveillance prostate cancer patients with biopsy Gleason 3+4 in only one core? Results of single center study after extensive central revision of histological specimens and mid-term follow-up 235
Active surveillance for clinically localized renal tumors: An updated review of current indications and clinical outcomes 217
Can we consider eligible for active surveillance prostate cancer patients with biopsy Gleason 3+4 in only one core? Results of single center study after extensive central revision of histological specimens and mid-term follow-up 216
MRI DISPLAYS THE PROSTATIC CANCER ANATOMY AND IMPROVES THE BUNDLES MANAGEMENT BEFORE ROBOT ASSISTED RADICAL PROSTATECTOMY 213
Can testis-sparing surgery for small testicular masses be considered a valid alternative to radical orchiectomy? A prospective single-center study 211
The prognostic impact of tumour size on cancer-specific and overall survival among patients with pathologic t3a renal cell carcinoma 209
The impact of a structured intensive modular training in the learning curve of robot assisted radical prostatectomy. 204
Holmium laser prostatectomy in a tertiary Italian center: A prospective cost analysis in comparison with bipolar TURP and open prostatectomy 204
Fibrotic Adhesive Toxic-fat (F.A.T.): the association of fibrotic and adhesive perirenal fat with peri-operative outcomes of robot-assisted par tial nephrectomy (RAPN) 201
ACCURATEZZA DELLA TC/PETCON 11-C-COLINA NELLA RISTADIAZIONE DEI PAZIENTI CON NEOPLASIA PROSTATICA RECIDIVA CON UNA SINGOLA LESIONE ALLA SCINTIGRAFIA OSSEA 197
Can we consider eligible for active surveillance prostate cancer patients with biopsy Gleason 3+4 in only one core? Results of single center study after extensive central revision of histological specimens and midterm follow-up 196
SURVIVAL, CONTINENCE AND POTENCY (SCP) RECOVERY AFTER RADICAL RETROPUBIC PROSTATECTOMY: A LONG-TERM COMBINED EVALUATION OF SURGICAL OUTCOMES 195
"In-bore" MRI-guided Prostate Biopsy Using an Endorectal Nonmagnetic Device: A Prospective Study of 70 Consecutive Patients 194
INFLUENZA DEL PSA TOTALE, DELLA PSA VELOCITY E DEL PSA DOUBLING TIME SULLA DETECTION RATE DELLA 11C COLINA PET/CT IN PAZIENTE CON RIPRESA BIOCHIMICA DOPO PROSTATECTOMIA RADICALE 192
COMPLICANZE E MORTALITÀ PERIOPERATORIE DELLA CISTECTOMIA RADICALE: ANALISI RETROSPETTIVA UTILIZZANDO UNA CLASSIFICAZIONE STANDARDIZZATA 187
The biopsy Gleason score 3+4 in a single core does not necessarily reflect an unfavourable pathological disease after radical prostatectomy in comparison with biopsy Gleason score 3+3: looking for larger selection criteria for active surveillance candidates 185
DUPLICE ENUCLEORESEZIONE RENALE ROBOTICA CON ACCESSO RETROPERITONEALE IN PAZIENTE CON PREGRESSA CHIRURGIA ADDOMINALE, TROMBOCITOPENIA CRONICA E CIRROSI EPATICA 181
Detection of nodal micro metastases with serial section, immunohistochemistry and real time-polymerase chain reaction in intermediate and high risk prostate cancer patients submitted to radical prostatectomy with extended pelvic lymph node dissection: A perspective study 179
NEFRECTOMIA PARZIALE ROBOTICA CON APPROCCIO RETROPERITONEALE A QUATTRO BRACCIA 178
Detection of nodal micro metastases with serial section, immunohistochemistry and real time-polymerase chain reaction in intermediate and high risk prostate cancer patients submitted to radical prostatectomy with extended pelvic lymph node dissection: A perspective study 177
SOPRAVVIVENZA CANCRO SPECIFICA NEI PAZIENTI SOTTOPOSTI A PROSTATECTOMIA RADICALE E MALATTIA AGGRESSIVA ALL’ESAME ISTOLOGICO DEFINITIVO. 174
INFLUENZA DEL PSA TOTALE, DELLA PSA VELOCITY E DEL PSA DOUBLING TIME SULLA DETECTION RATE DELLA 11C-COLINA PET/CT IN PAZIENTE CON RIPRESA BIOCHIMICA DOPO PROSTATECTOMIA RADICALE 171
PREOPERATIVE MULTI PARAMETRIC MAGNETIC RESONANCE IMAGING AND NEUROVASCULAR BUNDLE MANAGEMENT: SURGICAL PLAN CHANGE IN COURSE OF Robot-assISTED RADICAL PROSTATECTOMY 171
ElectRomagnetic synchronized real-time system for MRI-TRUS fusion targeted biopsy of prostate (Toshiba Aplio 500Tm) in a heterogeneous pa tients cohort: results and compa rison with systematic biopsy 170
Molecular diagnostic tools for the detection of nodal micrometastases in prostate cancer patients undergoing radical prostatectomy with extended pelvic lymph node dissection: a prospective study. 169
POSSIAMO INCLUDERE NELLA SORVEGLIANZA ATTIVA PER NEOPLASIA PROSTATICA, PAZIENTI CON CGS 3+4 IN UN UNICO PRELIEVO BIOPTICO? RISULTATI A MEDIO TERMINE DI UN SINGOLO CENTRO DOPO REVISIONE ISTOLOGICA SISTEMATICA DEI PRELIEVI BIOPTICI E DEI REPERTI OPERATORI 168
Patterns of positive surgical margins after surgery in prostate cancer pa tients and their association with clinical recurrence 168
Role of testis sparing surgery in the conservative management of small testicular masses: oncological and functional perspectives. 167
SURVIVAL, CONTINENCE AND POTENCY (SCP) RECOVERY AFTER RADICAL RETROPUBIC PROSTATECTOMY: A LONG-TERM COMBINED EVALUATION OF SURGICAL OUTCOMES 165
QUAL È L'IMPATTO DEI MARGINI POSITIVI SULLA RIPRESA BIOCHIMICA NEI PAZIENTI SOTTOPOSTI A PROSTATECTOMIA RADICALE PER CARCINOMA PROSTATICO? 165
Preoperative Staging With 11C-Choline PET/CT Is Adequately Accurate in Patients With Very High-Risk Prostate Cancer. 163
THE VALUE OF HISTOLOGICAL REVISION OF BIOPSY CORES IN PATIENTS SUITABLE FOR ACTIVE SURVEILLANCE: COMPARISON WITH SURGICAL SPECIMENS AFTER RADICAL PROSTATECTOMY AND CLINICAL FOLLOW-UP 163
The role of standard biopsy during an MRI-TRUS fusion targeted biopsy: A two cohort study in previous negative biopsy and active surveillance patients 163
LYMPH NODE DENSITY IN NODE-POSITIVE PATIENTS TREATED WITH RADICAL PROSTATECTOMY AND PELVIC LYMPH NODE DISSECTION 162
Small Renal Masses Managed With Active Surveillance: Predictors of Tumor Growth Rate After Long-Term Follow-Up. 162
Survival, continence and potency (SCP) recovery after radical retropubic prostatectomy: A long-term combined evaluation of surgical outcomes 162
RIPARAZIONE DI LESIONE DEL RETTO IN CORSO DI PROSTATECTOMIA RADICALE ROBOTICA UTILIZZANDO UN INNESTO PERITONEALE 161
The Prognostic Impact of Tumor Size on Cancer-Specific and Overall Survival Among Patients With Pathologic T3a Renal Cell Carcinoma 160
Survival, Continence and Potency (SCP) recovery after radical retropubic prostatectomy: A long-term combined evaluation of surgical outcomes. 159
State of the art of PET/CT with 11-choline and 18F-fluorocholine in the diagnosis and follow-up of localized and locally advanced prostate cancer 158
The value of histological revision of biopsy cores in patients suitable for active surveillance: comparison with surgical specimens after radical prostatectomy and clinical follow-up. 158
The prognostic impact of tumour size on cancer-specific and overall survival among patients with pathologic t3a renal cell carcinoma 158
IMPATTO ECONOMICO DELLA TERAPIA CHIRURGICA A CIELO APERTO ED ENDOSCOPICA PER L’IPERTROFIA PROSTATICA BENIGNA: ANALISI E CONFRONTO DEI COSTI SOSTENUTI NEL 2015 DA UN CENTRO DI TERZO LIVELLO 157
MAGNETIC RESONANCE/ULTR ASOUND-GUIDED FUSION PROSTATE BIOPSY: CANCER DETECTION RATE WITHIN CONSECUTIVE CORES TAKEN 157
LAPAROSCOPIC AND ROBOTIC URETERAL STENOSIS REPAIR: A MULTI-INSTITUTIONAL EXPERIENCE WITH A LONG-TERM FOLLOW UP 157
PREDICTING CANCER- SPECIFIC AND OTHER-CAUSE MORTALITY IN ELDERLY PATIENTS UNDERGOING RADICAL PROSTATECTOMY FOR PROSTATE CANCER: A COMPETING RISK ANALYSIS 156
RISULTATI MORFOLOGICI E FUNZIONALI DELLE NEOVESCICHE ILEALI ORTOTOPICHE:3 TECNICHE A CONFRONTO 151
LINFADENECTOMIA STANDARD VS ESTESA 151
V24: A new single barbed bidirectional suture (Filbloc, Assut SPA) for posterior muscolofascial reconstruction and knotless urethrovesical anastomosis during RARP 150
ROBOT-ASSISTED PARTIAL URETERECTOMY WITH END-TO-END ANASTOMOSIS FOR IATROGEN STENOSIS OF THE PROXIMAL URETER 147
INFLUENZA DELLA DEPRIVAZIONE ORMONALE SUL RISULTATO DELLA 11CCOLINA-PET/CT IN PAZIENTI CON NEOPLASIA PROSTATICA 146
THE PROGNOSTIC IMPACT OF TUMOR SIZE ON CANCER-SPECIFIC AND OVERALL SURVIVAL AMONG PATIENTS WITH PATHOLOGIC T3A RENAL CELL CARCINOMA 146
VALIDATION OF PRIAS ACTIVE SURVEILLANCE CRITERIA IN PATIENTS SUBMITED TO RADICAL PROSTATECTOMY 145
PROSTATECTOMIA ROBOTICA NERVE-SPARING: RUOLO DELLA RISONANZA MAGNETICA PREOPERATORIA 144
RUOLO DELLA TOMOGRAFIA COMPUTERIZZATA MULTIFASICA (TC) NEL MANAGEMENT CLINICO DELLE PICCOLE MASSE RENALI (SRMS). 142
PREOPERATIVE 11C-CHOLINE PET-CT IN INTERMEDIATE, HIGH RISK AND VERY HIGH RISK PROSTATE CANCER PATIENTS: IS THERE STILL ANY ROOM LEFT FOR IT? 139
THE IMPACT OF PELVIC LYMPH-NODE DISSECTION AND OF ITS EXTENT ON BIOCHEMICAL RELAPSE AFTER RADICAL PROSTATECTOMY IN PATIENTS WITH PATHOLOGICAL N0 OR NX AT INTERMEDIATE AND HIGH RISK OF LYMPH-NODE INVASION 135
INFLUENZA DELLA DEPRIVAZIONE ORMONALE SUL RISULTATO DELLA 11C COLINA PET/CT IN PAZIENTI CON NEOPLASIA PROSTATICA 135
SURVIVAL AND FUNCTIONAL OUTCOMES AFTER RADICAL PROSTATECTOMY: BIFECTA ACHIEVEMENT IN PATIENTS AGED ≥ 75 YEARS 135
THE IMPACT OF PATHOLOGIC FEATURES ON CANCER SPECIFIC SURVIVAL OF PATIENTS WITH CLINICALLY HIGH-RISK PROSTATE CANCER 135
CAN TESTIS-SPARING SURGERY BE A VALID ALTERNATIVE TO RADICAL ORCHIECTOMY IN SELECTED CASES? A PROSPECTIVE STUDY 133
THE IMPACT OF PELVIC LYMPH-NODE DISSECTION AND OF ITS EXTENT ON BIOCHEMICAL RELAPSE AFTER RADICAL PROSTATECTOMY IN PATIENTS WITH PATHOLOGICAL N0 OR NX AT INTERMEDIATE AND HIGH RISK OF LYMPH-NODE INVASION 132
QUAL'E' L'IMPATTO DEI MARGINI POSITIVI SULLA RIPRESA BIOCHIMICA NEI PAZIENTI SOTTOPOSTI A PROSTATECTOMIA RADICALE PER CARCINOMA 126
RUOLO DELLA LYMPH-NODE DENSITY NELL’OUTCOME ONCOLOGICO DEI PAZIENTI CON METASTASI LINFONODALI DA CARCINOMA prostatico SOTTOPOSTI A PROSTATECTOMIA RADICALE E LINFADENECTOMIA PELVICA 126
Small renal masses initially managed using active surveillance: results from a retrospective study with long-term follow-up. 122
V32: Robot-assisted partial cystectomy for the treatment of urachus acinar adenocarcinoma 114
PATIENTS WITH LYMPH-NODE METASTASIS AFTER RADICAL PROSTATECTOMY AND PELVIC LYMPH-NODE DISSECTION ARE NOT ALL SUBJECT TO THE SAME RISK OF CANCER DEATH: IDENTIFYING DIFFERENT RISKCATEGORY ACCORDING TO THE NUMBER OF POSITIVE NODES AND GLEASON SCORE 103
PRESERVATION OF INTERNAL VESICAL SPHINCTER AND PROXIMAL URETHRA DURINGRADICAL PROSTATECTOMY IMPROVES EARLIERCONTINENCE RECOVERY 99
Feasibility and setting of single docking HUGO RAS robot-assisted nephroureterectomy: first European experience 80
Totale 12.034
Categoria #
all - tutte 28.823
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 28.823


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021432 0 0 0 0 0 0 0 0 0 0 0 432
2021/20221.370 204 45 64 59 137 68 21 83 35 107 302 245
2022/20231.807 194 357 120 221 112 119 46 88 330 63 112 45
2023/2024452 41 64 15 48 48 90 45 34 5 32 11 19
2024/20251.597 61 251 123 121 251 101 86 65 8 158 49 323
2025/20263.565 332 189 284 202 444 197 329 94 910 374 136 74
Totale 12.034